A theme focused on continuing basic research and developing data analysis technologies based on comprehensive cancer gene and genome analysis using technologies such as cDNA microarrays and long-read sequencing. It also includes advancing the analysis platform through joint research with institutions including The Institute of Medical Science, The University of Tokyo.